ACADIAN ASSET MANAGEMENT LLC - TRACON PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 37 filers reported holding TRACON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of TRACON PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$55,000
+3.8%
20,523
+45.8%
0.00%–
Q3 2021$53,000
-75.6%
14,072
-58.0%
0.00%
-100.0%
Q2 2021$217,000
+10.2%
33,485
+39.5%
0.00%0.0%
Q1 2021$197,000–23,997–0.00%–
 Download
Other shareholders
TRACON PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Opaleye Management Inc. 4,764,508$9,004,9202.70%
Ikarian Capital, LLC 2,765,530$5,226,8511.19%
JOHNSON & JOHNSON 84,003$158,7660.05%
X-Square Capital, LLC 17,743$340.02%
BOOTHBAY FUND MANAGEMENT, LLC 258,844$489,2150.01%
LINDEN ADVISORS LP 454,916$859,7910.01%
HoyleCohen, LLC 13,000$24,5700.00%
MGO ONE SEVEN LLC 11,780$22,2640.00%
Bank of New York Mellon Corp 66,606$125,8850.00%
Citadel Advisors 24,700$46,6830.00%
View complete list of TRACON PHARMACEUTICALS INC shareholders